Stefan C Müller Selected Research

Mediator Complex

9/2018	The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
6/2018	The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells.
1/2018	The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma.
12/2017	The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
1/2017	Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.
4/2016	Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer types.
9/2015	Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan C Müller Research Topics

Disease

65	Neoplasms (Cancer) 01/2020 - 08/2003
33	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 06/2009
31	Urinary Bladder Neoplasms (Bladder Cancer) 09/2018 - 11/2003
24	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 06/2005
19	Carcinoma (Carcinomatosis) 01/2018 - 03/2007
13	Carcinogenesis 11/2018 - 06/2005
7	Hyperplasia 11/2018 - 06/2005
6	Neoplasm Metastasis (Metastasis) 09/2018 - 05/2007
5	Disease Progression 01/2017 - 01/2009
5	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2015 - 07/2009
4	Oxyphilic Adenoma (Oncocytoma) 08/2012 - 11/2010
3	Non-Muscle Invasive Bladder Neoplasms 04/2014 - 10/2011
3	Pathologic Constriction (Stenosis) 01/2014 - 08/2004
3	Transitional Cell Carcinoma 07/2011 - 03/2005
3	Testicular Neoplasms (Testicular Cancer) 07/2009 - 08/2003
2	Urologic Diseases (Urinary Tract Disease) 01/2018 - 01/2015
2	Seminoma 09/2015 - 08/2003
2	Urolithiasis 02/2015 - 11/2005
2	Kidney Neoplasms (Kidney Cancer) 10/2013 - 06/2009
2	Lymphatic Metastasis 08/2012 - 01/2010
2	Carcinoma in Situ 01/2011 - 02/2010
2	Hypoxia (Hypoxemia) 03/2009 - 11/2007
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2008 - 01/2008
2	Thrombosis (Thrombus) 01/2008 - 05/2007
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 09/2018
1	Bezoars (Bezoar) 03/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Ataxia (Dyssynergia) 02/2017
1	Nonseminomatous germ cell tumor 09/2015
1	Teratoma (Teratoid Tumor) 09/2015
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 09/2015
1	Urinary Calculi (Urinary Calculus) 02/2015
1	Shock 02/2015
1	Testicular Germ Cell Tumor 01/2015
1	Urinary Incontinence 01/2014

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 08/2019 - 01/2008
16	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 06/2005
11	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2011
10	Histones (Histone)IBA 08/2016 - 01/2010
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2005
7	Messenger RNA (mRNA)IBA 01/2020 - 08/2012
7	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2012
7	Mediator ComplexIBA 09/2018 - 09/2015
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013 - 06/2005
6	Lysine (L-Lysine)FDA Link 03/2012 - 01/2010
5	Cell-Free Nucleic AcidsIBA 10/2016 - 07/2010
4	Long Noncoding RNAIBA 09/2015 - 01/2015
3	ST 679IBA 09/2018 - 09/2015
3	Pharmaceutical PreparationsIBA 08/2012 - 03/2005
3	Mitochondrial DNA (mtDNA)IBA 07/2012 - 08/2008
2	Transfer RNA (tRNA)IBA 11/2018 - 11/2016
2	AndrogensIBA 11/2018 - 01/2015
2	CalciumIBA 09/2018 - 03/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017 - 08/2012
2	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 07/2009
2	Prostaglandin Receptors (Prostaglandin Receptor)IBA 01/2014 - 12/2012
2	ProstaglandinsIBA 01/2014 - 12/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 06/2013 - 12/2010
2	Prostate-Specific Antigen (Semenogelase)IBA 06/2013 - 03/2007
2	AntibodiesIBA 02/2012 - 01/2010
2	histone H3 trimethyl Lys4IBA 10/2011 - 11/2010
2	SurvivinIBA 11/2009 - 05/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2009 - 11/2007
2	carboxyamido-triazole (carboxyamidotriazole)IBA 03/2005 - 09/2004
1	DysferlinIBA 01/2020
1	Piwi-Interacting RNAIBA 08/2019
1	Protein Subunits (Protein Subunit)IBA 01/2019
1	Apelin ReceptorsIBA 01/2019
1	ApelinIBA 01/2019
1	ParaffinIBA 11/2018
1	Formaldehyde (Formol)FDA Link 11/2018
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2018
1	AntigensIBA 01/2018
1	oligomycin sensitivity-conferring protein (complex V)IBA 08/2017
1	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 08/2017
1	Adenosine Triphosphate (ATP)IBA 08/2017
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2017
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2016
1	Untranslated RNA (Noncoding RNA)IBA 10/2016
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2016
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015
1	bicalutamide (Casodex)FDA LinkGeneric 01/2015
1	Fetal Proteins (Fetoprotein)IBA 01/2015

Therapy/Procedure

18	Cystectomy 01/2017 - 01/2008
12	Therapeutics 01/2021 - 05/2006
7	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 03/2007
5	Nephrectomy 01/2015 - 05/2007
5	Drug Therapy (Chemotherapy) 01/2015 - 08/2003
4	Radiotherapy 01/2021 - 08/2006
4	Lymph Node Excision (Lymph Node Dissection) 07/2011 - 01/2009
3	Immunotherapy 01/2019 - 09/2004
2	Urinary Diversion (Ileal Conduit) 01/2021 - 11/2005
2	Neoadjuvant Therapy 01/2017 - 10/2013
2	Lasers (Laser) 01/2012 - 11/2007
2	Adjuvant Chemotherapy 09/2010 - 02/2010
1	Psychology Biofeedback (Biofeedback) 02/2017
1	Precision Medicine 04/2015
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 02/2015
1	Nephroureterectomy 01/2015